These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2676041)

  • 1. A controlled study of combined hormonal and psychological treatment for sexual unresponsiveness in women.
    Dow MG; Gallagher J
    Br J Clin Psychol; 1989 Sep; 28(3):201-12. PubMed ID: 2676041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of hormonal and psychological treatment for female sexual unresponsiveness: a comparative study.
    Carney A; Bancroft J; Mathews A
    Br J Psychiatry; 1978 Oct; 133():339-46. PubMed ID: 709007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials.
    Tuiten A; van Rooij K; Bloemers J; Eisenegger C; van Honk J; Kessels R; Kingsberg S; Derogatis LR; de Leede L; Gerritsen J; Koppeschaar HPF; Olivier B; Everaerd W; Frijlink HW; Höhle D; de Lange RPJ; Böcker KBE; Pfaus JG
    J Sex Med; 2018 Feb; 15(2):201-216. PubMed ID: 29289554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors related to successful outcome in the treatment of sexually unresponsive women.
    Whitehead A; Mathews A
    Psychol Med; 1986 May; 16(2):373-8. PubMed ID: 3726010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of exogenous testosterone on sexuality and mood of normal men.
    Anderson RA; Bancroft J; Wu FC
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1503-7. PubMed ID: 1464655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual unresponsiveness and orgastic dysfunction: an empirical comparison.
    Clement U
    J Sex Marital Ther; 1980; 6(4):274-81. PubMed ID: 6965177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
    Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial.
    Fernandes T; Costa-Paiva LH; Pinto-Neto AM
    J Sex Med; 2014 May; 11(5):1262-70. PubMed ID: 24612478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
    Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of effects of testosterone administration on sexual arousal in women.
    Tuiten A; Van Honk J; Koppeschaar H; Bernaards C; Thijssen J; Verbaten R
    Arch Gen Psychiatry; 2000 Feb; 57(2):149-53; discussion 155-6. PubMed ID: 10665617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards in Studies of Psychotherapy and Pharmacotherapy Interventions for HSDD.
    Clayton AH; Pyke RE
    J Sex Marital Ther; 2017 Apr; 43(3):206-209. PubMed ID: 27649260
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
    Orri M; Abraham L; Giraldi A
    J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.
    Davis S; Papalia MA; Norman RJ; O'Neill S; Redelman M; Williamson M; Stuckey BG; Wlodarczyk J; Gard'ner K; Humberstone A
    Ann Intern Med; 2008 Apr; 148(8):569-77. PubMed ID: 18413618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological and hormonal factors in the treatment of female sexual dysfunction.
    Mathews A; Whitehead A; Kellett J
    Psychol Med; 1983 Feb; 13(1):83-92. PubMed ID: 6844470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel combined drug treatments for women with hypoactive sexual desire disorder.
    Poels S; Bloemers J; van Rooij K; Koppeschaar H; Olivier B; Tuiten A
    Pharmacol Biochem Behav; 2014 Jun; 121():71-9. PubMed ID: 24534417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
    Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
    J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.
    van Lunsen RHW; Zimmerman Y; Coelingh Bennink HJT; Termeer HMM; Appels N; Fauser BCJM; Laan E
    Contraception; 2018 Jul; 98(1):56-62. PubMed ID: 29490289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
    Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
    J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.